Sanford among first sites to offer EXTEND trial
Sanford Health is among the first sites to offer the EXTEND trial, a clinical trial that will test the ability of the drug tocilizumab to slow disease progression and help maintain natural insulin production in individuals with newly diagnosed type 1 diabetes. Type 1 diabetes is the focus of The Sanford Project, a cornerstone research […]